Does ketoralac affect blood sugar levels in patients with pre-existing diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Ketorolac Affect Blood Sugar Levels?

No, ketorolac does not directly affect blood sugar levels in patients with diabetes. Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) with potent analgesic properties that does not have documented effects on glucose metabolism 1.

Evidence Base

The available evidence does not identify ketorolac as a medication that impacts glycemic control:

  • Comprehensive reviews of drug-induced hyperglycemia do not list ketorolac or NSAIDs (other than specific exceptions) as agents that alter blood glucose levels 2.

  • Major diabetes care guidelines from the American Diabetes Association specifically identify medications that require glucose monitoring considerations—including glucocorticoids, statins, thiazide diuretics, certain HIV medications, and second-generation antipsychotics—but do not mention ketorolac or standard NSAIDs 3.

  • Clinical pharmacology literature on ketorolac extensively documents its adverse effect profile (gastrointestinal bleeding, renal impairment, platelet inhibition) but does not include hyperglycemia or hypoglycemia among its known effects 4, 1.

Important Clinical Distinction

Do not confuse ketorolac with medications that DO affect blood sugar:

  • Glucocorticoids (like prednisone or dexamethasone) cause significant hyperglycemia in 56-86% of patients and require intensive insulin management 3.

  • Certain antibiotics (fluoroquinolones, clarithromycin, linezolid) can cause hypoglycemia, particularly when combined with sulfonylureas or meglitinides 5.

Practical Management

For patients with diabetes receiving ketorolac:

  • No special glucose monitoring is required beyond standard diabetes management 4.

  • Standard precautions for ketorolac use apply: avoid in patients with renal impairment, gastrointestinal bleeding risk, or compromised hemostasis 4.

  • Limit duration to 5 days or less and use the lowest effective dose to minimize NSAID-related adverse effects 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotics Impacting Insulin and Glucose Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.